セッション詳細

[JK]JSIBD-KASID Joint Symposium
言語フリーでつながる日韓シンポジウム:お隣の国ではどう治療している?
How Are IBD Patients Treated in the Neighboring Countries?

2026年11月28日(土) 10:30 〜 12:10
第3会場(大会議室)
Moderator:Ryuichi Okamoto(Institute of Science Tokyo), Jeong-Sik Byeon(University of Ulsan/President-Elect of KASID)
Session 1 (JK1,JK2)
Differences in Pharmaceutical Practices and Healthcare Systems Between Japan and South Korea
Session 2 (JK3, JK4) 
Case Discussion

[JK1]Current Status of Biosimilars and Use of S1P Receptor Modulators in Korea

Hyuk Yoon (Seoul National University College of Medicine, Seoul, Korea / Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea)

[JK2]Treatment of Ulcerative Colitis in Japan and Korea: How Guidelines and Reimbursement Shape Clinical Practice

Shintaro Akiyama, MD, PhD (Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Japan)

[JK4]Treatment Decisions in an Older Patient with Ulcerative Colitis Complicated by Pulmonary Embolism

Shunsuke Shibui1,2, Taku Kobayashi2, Reiko Kunisaki1 (1 Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan
2 Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan)